Clinical Trial Update: Phase I/II Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of GC310 Injection in Patients With Wilson's Disease (WD) [Phase 1, Phase 2]

View source ↗

Summary

A Phase I/II clinical trial is planned to evaluate GC310 Injection in Wilson disease. Recruitment has not yet begun.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Wilson Disease

Drugs mentioned

• GC310 Injection (GC310)

Snippet

Sponsor: GeneCradle Inc | Conditions: Wilson Disease | Phase 1, Phase 2 | Status: NOT_YET_RECRUITING